Identification of Circulating miR-762 as a Novel Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer
Background: MicroRNAs (miRNAs) have been demonstrated to play critical roles in tumorigenesis of non-small cell lung cancer (NSCLC), and circulating miRNAs are a valuable source of biomarkers for the clinical management of NSCLC. The aim of this study was to determine the value of serum miR-762 as a...
Main Authors: | Lei Chen, Yunxia Li, Jingshu Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-12-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/1533033820964222 |
Similar Items
-
miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer
by: Peng Ge, et al.
Published: (2019-12-01) -
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
by: Valladares-Ayerbes Manuel, et al.
Published: (2012-09-01) -
miR-762 can negatively regulate menin in ovarian cancer
by: Hou R, et al.
Published: (2017-04-01) -
Serum miR-185 Is a Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer
by: Jinghao Liu MD, et al.
Published: (2020-11-01) -
MicroRNA miR-762 expression in colorectal cancer CT26 cells
by: 洪苙榛